OraSure Technologies, Inc.  

(Public, NASDAQ:OSUR)   Watch this stock  
5.06
-0.18 (-3.44%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.01 - 5.30
52 week 4.41 - 10.93
Open 5.28
Vol / Avg. 542,166.00/668,389.00
Mkt cap 287.11M
P/E 266.18
Div/yield     -
EPS 0.02
Shares 56.42M
Beta 1.56
Inst. own 83%
Aug 5, 2015
Q2 2015 OraSure Technologies, Inc. Earnings Conference Call - 5:00PM EDT - Add to calendar
Aug 5, 2015
Q2 2015 OraSure Technologies Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 23, 2015
OraSure Technologies Inc at JMP Securities Life Sciences Conference
Jun 2, 2015
OraSure Technologies Inc at Jefferies Global Healthcare Conference
May 18, 2015
OraSure Technologies Inc at UBS Global Healthcare Conference
May 11, 2015
OraSure Technologies Inc Annual Shareholders Meeting
May 6, 2015
Q1 2015 OraSure Technologies Inc Earnings Call - Webcast
May 6, 2015
Q1 2015 OraSure Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 0.42% -4.33%
Operating margin -1.07% -4.51%
EBITD margin - -3.75%
Return on average assets 0.25% -2.47%
Return on average equity 0.29% -2.89%
Employees 320 -
CDP Score - -

Address

150 WEBSTER ST
BETHLEHEM, PA 18015
United States - Map
+1-503-6416115 (Phone)
+1-610-8821830 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Officers and directors

Douglas G. Watson Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas A. Michels President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ronald H. Spair Chief Financial Officer, Chief Operating Officer, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Anthony II Zezzo II Executive Vice President - Marketing and Sales
Age: 61
Bio & Compensation  - Reuters
Mark L. Kuna Senior Vice President - Finance, Controller, Assistant Secretary
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jack E. Jerrett Senior Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Celano Independent Director
Age: 56
Bio & Compensation  - Reuters
Ronny B. Lancaster Independent Director
Age: 63
Bio & Compensation  - Reuters
Charles W. Patrick Independent Director
Age: 60
Bio & Compensation  - Reuters
Roger L. Pringle Independent Director
Age: 74
Bio & Compensation  - Reuters